Monlunabant

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Monlunabant, covering 2025-11-18 to 2025-11-18. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian Men [Phase 1]

See pricing